232 related articles for article (PubMed ID: 20484040)
1. Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts.
Huang CF; Lira C; Chu K; Bilen MA; Lee YC; Ye X; Kim SM; Ortiz A; Wu FL; Logothetis CJ; Yu-Lee LY; Lin SH
Cancer Res; 2010 Jun; 70(11):4580-9. PubMed ID: 20484040
[TBL] [Abstract][Full Text] [Related]
2. Angiomotin is a novel component of cadherin-11/β-catenin/p120 complex and is critical for cadherin-11-mediated cell migration.
Ortiz A; Lee YC; Yu G; Liu HC; Lin SC; Bilen MA; Cho H; Yu-Lee LY; Lin SH
FASEB J; 2015 Mar; 29(3):1080-91. PubMed ID: 25466890
[TBL] [Abstract][Full Text] [Related]
3. Androgen depletion up-regulates cadherin-11 expression in prostate cancer.
Lee YC; Cheng CJ; Huang M; Bilen MA; Ye X; Navone NM; Chu K; Kao HH; Yu-Lee LY; Wang Z; Lin SH
J Pathol; 2010 May; 221(1):68-76. PubMed ID: 20191612
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
5. Cadherin-11 endocytosis through binding to clathrin promotes cadherin-11-mediated migration in prostate cancer cells.
Satcher RL; Pan T; Bilen MA; Li X; Lee YC; Ortiz A; Kowalczyk AP; Yu-Lee LY; Lin SH
J Cell Sci; 2015 Dec; 128(24):4629-41. PubMed ID: 26519476
[TBL] [Abstract][Full Text] [Related]
6. DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.
Tripathi V; Popescu NC; Zimonjic DB
Oncogene; 2014 Feb; 33(6):724-33. PubMed ID: 23376848
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
Murali AK; Norris JS
J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
[TBL] [Abstract][Full Text] [Related]
8. Cadherin-11 promotes the metastasis of prostate cancer cells to bone.
Chu K; Cheng CJ; Ye X; Lee YC; Zurita AJ; Chen DT; Yu-Lee LY; Zhang S; Yeh ET; Hu MC; Logothetis CJ; Lin SH
Mol Cancer Res; 2008 Aug; 6(8):1259-67. PubMed ID: 18708358
[TBL] [Abstract][Full Text] [Related]
9. Truncation of the extracellular region abrogrates cell contact but retains the growth-suppressive activity of E-cadherin.
Sasaki CY; Lin H; Morin PJ; Longo DL
Cancer Res; 2000 Dec; 60(24):7057-65. PubMed ID: 11156412
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells.
Chen L; Cao R; Wang G; Yuan L; Qian G; Guo Z; Wu CL; Wang X; Xiao Y
Med Oncol; 2017 Jul; 34(7):127. PubMed ID: 28573641
[TBL] [Abstract][Full Text] [Related]
11. An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells.
Li S; Jiao J; Lu Z; Zhang M
Oncol Rep; 2009 May; 21(5):1223-33. PubMed ID: 19360298
[TBL] [Abstract][Full Text] [Related]
12. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
Deep G; Jain AK; Ramteke A; Ting H; Vijendra KC; Gangar SC; Agarwal C; Agarwal R
Mol Cancer; 2014 Feb; 13():37. PubMed ID: 24565133
[TBL] [Abstract][Full Text] [Related]
13. Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer.
Gao J; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
Prostate; 2007 Mar; 67(4):348-60. PubMed ID: 17221837
[TBL] [Abstract][Full Text] [Related]
14. SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells.
López-Moncada F; Torres MJ; Lavanderos B; Cerda O; Castellón EA; Contreras HR
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682554
[TBL] [Abstract][Full Text] [Related]
15. Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells.
Deep G; Gangar SC; Agarwal C; Agarwal R
Cancer Prev Res (Phila); 2011 Aug; 4(8):1222-32. PubMed ID: 21546539
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation.
Wei J; Xu G; Wu M; Zhang Y; Li Q; Liu P; Zhu T; Song A; Zhao L; Han Z; Chen G; Wang S; Meng L; Zhou J; Lu Y; Wang S; Ma D
Anticancer Res; 2008; 28(1A):327-34. PubMed ID: 18383865
[TBL] [Abstract][Full Text] [Related]
17. Trefoil factor 1 suppression of E-CADHERIN enhances prostate carcinoma cell invasiveness and metastasis.
Bougen NM; Amiry N; Yuan Y; Kong XJ; Pandey V; Vidal LJ; Perry JK; Zhu T; Lobie PE
Cancer Lett; 2013 May; 332(1):19-29. PubMed ID: 23266572
[TBL] [Abstract][Full Text] [Related]
18. Osteoblast-derived WNT-induced secreted protein 1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126.
Tai HC; Chang AC; Yu HJ; Huang CY; Tsai YC; Lai YW; Sun HL; Tang CH; Wang SW
Oncotarget; 2014 Sep; 5(17):7589-98. PubMed ID: 25277191
[TBL] [Abstract][Full Text] [Related]
19. The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition.
Yee DS; Tang Y; Li X; Liu Z; Guo Y; Ghaffar S; McQueen P; Atreya D; Xie J; Simoneau AR; Hoang BH; Zi X
Mol Cancer; 2010 Jun; 9():162. PubMed ID: 20573255
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasis.
Lee YC; Bilen MA; Yu G; Lin SC; Huang CF; Ortiz A; Cho H; Song JH; Satcher RL; Kuang J; Gallick GE; Yu-Lee LY; Huang W; Lin SH
Mol Cancer Res; 2013 Nov; 11(11):1401-11. PubMed ID: 23913163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]